Veeva Systems, Inc provides cloud-based solutions for the global life sciences industry, enabling them to use modern cloud-based architectures and mobile applications for their critical business functions while maintaining industry-specific functionality and regulatory compliance. The company’s CEO and Director have recently sold shares of the company’s stock, and institutional investors have modified their holdings. Veeva Systems has a market capitalization of $26.88 billion, with a PE ratio of 57.35, a price-to-earnings-growth ratio of 3.92, and a beta of 0.90. The stock has a 50-day simple moving average of $169.92 and a 200-day simple moving average of $170.24. Finally, Veeva Systems is rated a “hold” by Truist Financial and has received multiple ratings from various analysts.
Truist Financial has reiterated its “hold” rating for Veeva Systems (NYSE:VEEV) in a report released on Friday, according to MarketBeat.com. The firm has set a $195.00 target price for the stock. Several other analysts have also recently commented on the company, with Piper Sandler raising its target price to $212.00, JMP Securities boosting its price target to $230.00 and giving the stock a “market outperform” rating, and SVB Leerink and Raymond James lowering their respective price targets on the stock. Barclays also lowered its price target on the company. In total, twelve research analysts have rated Veeva Systems as a “hold,” while thirteen have given it a “buy” rating. MarketBeat data indicates a consensus rating of “Moderate Buy” and a consensus target price of $204.39 for the stock. VEEV opened at $172.63 on Friday, with a 50-day simple moving average of $169.92 and a 200-day simple moving average of $170.24. The company has a market capitalization of $26.88 billion, a PE ratio of 57.35, a price-to-earnings-growth ratio of 3.92, and a beta of 0.90. Its 1-year low is $151.02, and its 1-year high is $232.26.
Veeva Systems CEO, Peter P. Gassner, and Director, Matthew J. Wallach, have both recently sold shares of the company’s stock. Gassner sold 28,506 shares on January 3rd for an average price of $159.77, totaling $4,554,403.62. Wallach sold 10,000 shares on the same day for an average price of $159.80, totaling $1,598,000. Following the sale, Wallach now owns 2,846 shares of Veeva Systems stock, valued at $454,790.80. Overall, insiders have sold 97,224 shares worth $16,003,460 in the last quarter, with insiders owning 13.23% of the company’s stock.
Institutional investors and hedge funds have also made changes to their holdings of Veeva Systems. CI Investments Inc. increased its position in the company by 964.7% in the third quarter, while Lindbrook Capital LLC and HM Payson & Co. increased their positions by 143.0% and 400.0%, respectively, in the fourth quarter. My Personal CFO LLC and Glass Jacobson Investment Advisors LLC both purchased new stakes in the company in the fourth quarter. Currently, 78.76% of Veeva Systems’ stock is owned by hedge funds and other institutional investors.
Veeva Systems is a technology company with a market capitalization of $26.88 billion, a PE ratio of 57.35, a price-to-earnings-growth ratio of 3.92, and a beta of 0.90. The company’s stock opened at $172.63 on Friday, with a 50-day simple moving average of $169.92 and a 200-day simple moving average of $170.24. Veeva Systems has a 1-year low of $151.02 and a 1-year high of $232.26.
Veeva Systems, Inc is a company that provides industry cloud solutions for the global life sciences industry. The company’s solutions allow pharmaceutical and other life sciences companies to use cloud-based architectures and mobile applications for their critical business functions while maintaining industry-specific functionality and regulatory compliance. For more news and analysts’ ratings on Veeva Systems, you can sign up for MarketBeat.com’s free daily email newsletter.
Don’t miss interesting posts on Famousbio
